Poseida Therapeutics to Present at Upcoming Investor Conferences
Poseida Therapeutics (Nasdaq: PSTX), a clinical-stage company focused on allogeneic cell therapy and genetic medicines, has announced its participation in two upcoming investor conferences in September 2024. The company will engage in fireside chats at the H.C. Wainwright 26th Annual Global Investment Conference on September 9 at 10:30am ET and the 2024 Cantor Global Healthcare Conference on September 17 at 1:20pm ET.
These presentations offer investors an opportunity to gain insights into Poseida's progress in developing non-viral treatments for cancer and rare diseases. Live webcasts of both fireside chats will be accessible on Poseida's website, with replays available for approximately 90 days post-presentation.
Poseida Therapeutics (Nasdaq: PSTX), un'azienda in fase clinica focalizzata sulla terapia cellulare allogenica e le medicine genetiche, ha annunciato la sua partecipazione a due conferenze per investitori in programma a settembre 2024. L'azienda parteciperà a chiacchierate informali durante il 26° Annual Global Investment Conference di H.C. Wainwright il 9 settembre alle 10:30 ET e il 2024 Cantor Global Healthcare Conference il 17 settembre alle 13:20 ET.
Queste presentazioni offrono agli investitori l'opportunità di acquisire informazioni sui progressi di Poseida nello sviluppo di trattamenti non virali per il cancro e le malattie rare. I webcast dal vivo di entrambe le chiacchierate informali saranno accessibili sul sito web di Poseida, con repliche disponibili per circa 90 giorni dopo la presentazione.
Poseida Therapeutics (Nasdaq: PSTX), una empresa en etapa clínica enfocada en la terapia celular alogénica y los medicamentos genéticos, ha anunciado su participación en dos próximas conferencias de inversores en septiembre de 2024. La empresa participará en charlas informales en la 26ª Conferencia Anual de Inversión Global de H.C. Wainwright el 9 de septiembre a las 10:30 am ET y en la Conferencia Global de Atención Médica 2024 de Cantor el 17 de septiembre a la 1:20 pm ET.
Estas presentaciones ofrecen a los inversores la oportunidad de obtener información sobre el progreso de Poseida en el desarrollo de tratamientos no virales para el cáncer y enfermedades raras. Los webcasts en vivo de ambas charlas estarán disponibles en el sitio web de Poseida, con repeticiones accesibles durante aproximadamente 90 días después de la presentación.
포세이다 테라퓨틱스 (Nasdaq: PSTX)는 동종 세포 치료법과 유전자 의약품에 중점을 둔 임상 단계 회사로, 2024년 9월에 열리는 두 개의 투자자 회의에 참여한다고 발표했습니다. 이 회사는 9월 9일 오전 10:30 ET에 H.C. 웨인라이트 제26회 글로벌 투자 회의와 9월 17일 오후 1:20 ET에 2024 캔토 글로벌 헬스케어 회의에서 화로 앞 대화에 참여할 예정입니다.
이 발표는 투자자들에게 포세이다가 암과 희귀 질환을 위한 비바이러스 치료법 개발에 관한 진전을 알릴 수 있는 기회를 제공합니다. 두 번의 화로 앞 대화는 포세이다의 웹사이트에서 실시간 웹캐스트로 시청할 수 있으며, 발표 후 약 90일 동안 다시 볼 수 있는 서비스도 제공됩니다.
Poseida Therapeutics (Nasdaq: PSTX), une entreprise en phase clinique axée sur la thérapie cellulaire allogénique et les médicaments génétiques, a annoncé sa participation à deux prochaines conférences pour investisseurs en septembre 2024. L'entreprise participera à des discussions informelles lors de la 26ème Conférence Annuelle d'Investissement Mondiale H.C. Wainwright le 9 septembre à 10h30 ET et à la Conférence Mondiale de la Santé 2024 de Cantor le 17 septembre à 13h20 ET.
Ces présentations offrent aux investisseurs l'occasion d'obtenir des informations sur les avancées de Poseida dans le développement de traitements non viraux pour le cancer et les maladies rares. Les webcasts en direct des deux discussions informelles seront accessibles sur le site web de Poseida, avec des rediffusions disponibles pendant environ 90 jours après la présentation.
Poseida Therapeutics (Nasdaq: PSTX), ein klinisches Unternehmen, das sich auf allogene Zelltherapie und genetische Medikamente konzentriert, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2024 bekannt gegeben. Das Unternehmen wird am 9. September um 10:30 Uhr ET in informellen Gesprächen auf der 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright und am 17. September um 13:20 Uhr ET auf der 2024 Cantor Global Healthcare Conference präsent sein.
Diese Präsentationen bieten Investoren die Möglichkeit, Einblicke in Poseidas Fortschritte bei der Entwicklung nicht-viraler Behandlungen für Krebs und seltene Krankheiten zu erhalten. Live-Webcasts beider informeller Gespräche werden auf Poseidas Webseite verfügbar sein, mit Wiederholungen, die etwa 90 Tage nach der Präsentation zur Verfügung stehen.
- None.
- None.
H.C. Wainwright 26th Annual Global Investment Conference
Date: Monday, September 9, 2024
Time: 10:30am ET
2024 Cantor Global Healthcare Conference
Date: Tuesday, September 17, 2024
Time: 1:20pm ET
Live webcasts of the fireside chats will be available on the Investors & Media Section of Poseida's website, www.poseida.com. A replay of the webcast will be available for approximately 90 days following the presentation.
About Poseida Therapeutics, Inc.
Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes investigational allogeneic CAR-T cell therapies for both solid tumors and hematologic cancers as well as investigational in vivo genetic medicines that address patient populations with high unmet medical need. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVER™ Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing. The Company has formed strategic collaborations with Roche and Astellas to unlock the promise of cell therapies for cancer patients. Learn more at www.poseida.com and connect with Poseida on X and LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/poseida-therapeutics-to-present-at-upcoming-investor-conferences-302234400.html
SOURCE Poseida Therapeutics, Inc.
FAQ
When is Poseida Therapeutics (PSTX) presenting at the H.C. Wainwright Global Investment Conference in 2024?
What is the date and time of Poseida Therapeutics' (PSTX) presentation at the 2024 Cantor Global Healthcare Conference?
How can investors access Poseida Therapeutics' (PSTX) presentations at the September 2024 conferences?
What type of treatments is Poseida Therapeutics (PSTX) developing?
